共 16 条
Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314
被引:0
|作者:
Kimbria J. Blake
Pankaj Baral
Tiphaine Voisin
Ashira Lubkin
Felipe Almeida Pinho-Ribeiro
Kelsey L. Adams
David P. Roberson
Yuxin C. Ma
Michael Otto
Clifford J. Woolf
Victor J. Torres
Isaac M. Chiu
机构:
[1] Division of Immunology,Department of Microbiology and Immunobiology
[2] Harvard Medical School,Department of Microbiology
[3] New York University School of Medicine,Department of Neurobiology
[4] Harvard Medical School,undefined
[5] F.M. Kirby Neurobiology Center,undefined
[6] Boston Children’s Hospital,undefined
[7] Pathogen Molecular Genetics Section,undefined
[8] Laboratory of Bacteriology,undefined
[9] National Institute of Allergy and Infectious Disease,undefined
[10] National Institutes of Health,undefined
来源:
Nature Communications
|
/
9卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
The hallmark of many bacterial infections is pain. The underlying mechanisms of pain during live pathogen invasion are not well understood. Here, we elucidate key molecular mechanisms of pain produced during live methicillin-resistant Staphylococcus aureus (MRSA) infection. We show that spontaneous pain is dependent on the virulence determinant agr and bacterial pore-forming toxins (PFTs). The cation channel, TRPV1, mediated heat hyperalgesia as a distinct pain modality. Three classes of PFTs—alpha-hemolysin (Hla), phenol-soluble modulins (PSMs), and the leukocidin HlgAB—directly induced neuronal firing and produced spontaneous pain. From these mechanisms, we hypothesized that pores formed in neurons would allow entry of the membrane-impermeable sodium channel blocker QX-314 into nociceptors to silence pain during infection. QX-314 induced immediate and long-lasting blockade of pain caused by MRSA infection, significantly more than lidocaine or ibuprofen, two widely used clinical analgesic treatments.
引用
收藏
相关论文